Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2A1 ATP2A2 ATP2A3	1.78e-05	11	97	3	GO:0005388
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	RAET1G ULBP2 RAET1L	7.19e-05	17	97	3	GO:0046703
GeneOntologyMolecularFunction	calcium-dependent ATPase activity	ATP2A1 ATP2A3	1.39e-04	4	97	2	GO:0030899
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP2A1 ATP2A2 ATP2A3	7.06e-04	36	97	3	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP2A1 ATP2A2 ATP2A3	7.06e-04	36	97	3	GO:0015662
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	ITPR3 TRPV3 ATP2A1 ATP2A2 ATP2A3	8.53e-04	151	97	5	GO:0015085
GeneOntologyBiologicalProcess	susceptibility to natural killer cell mediated cytotoxicity	RAET1G ULBP2 RAET1L	7.55e-06	9	94	3	GO:0042271
GeneOntologyBiologicalProcess	organelle localization	IL13 CHMP6 SYNE1 CEP290 SPC24 LLGL1 AKAP9 CADPS TACC1 SCRIB ATP2A1 ATP2A2 DYNC1H1	1.78e-05	703	94	13	GO:0051640
GeneOntologyBiologicalProcess	calcium ion transport from cytosol to endoplasmic reticulum	ATP2A2 ATP2A3	2.05e-05	2	94	2	GO:1903515
GeneOntologyBiologicalProcess	positive regulation of natural killer cell mediated cytotoxicity	RAET1G ULBP2 RAET1L VAV1	3.26e-05	40	94	4	GO:0045954
GeneOntologyBiologicalProcess	nuclear chromosome segregation	REC8 CHMP6 BAZ1B TEX15 SPC24 MLH3 SMARCA2 MAEL DYNC1H1	3.60e-05	356	94	9	GO:0098813
GeneOntologyBiologicalProcess	positive regulation of macrophage activation	IL13 RAET1G ULBP2 RAET1L	3.97e-05	42	94	4	GO:0043032
GeneOntologyBiologicalProcess	positive regulation of natural killer cell mediated immunity	RAET1G ULBP2 RAET1L VAV1	4.78e-05	44	94	4	GO:0002717
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	RAET1G ULBP2 RAET1L	4.92e-05	16	94	3	GO:0002486
GeneOntologyBiologicalProcess	organelle fission	REC8 RAD51B CHMP6 TOM1L1 BAZ1B TEX15 SPC24 MLH3 MAEL SLX4 MIEF2	5.75e-05	571	94	11	GO:0048285
GeneOntologyBiologicalProcess	meiosis I	REC8 RAD51B TEX15 MLH3 MAEL SLX4	5.75e-05	147	94	6	GO:0007127
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	RAET1G ULBP2 RAET1L	5.95e-05	17	94	3	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	RAET1G ULBP2 RAET1L	5.95e-05	17	94	3	GO:0002476
GeneOntologyBiologicalProcess	magnesium ion homeostasis	CNNM2 CNNM3 CNNM1	5.95e-05	17	94	3	GO:0010960
GeneOntologyBiologicalProcess	positive regulation of endoplasmic reticulum calcium ion concentration	ATP2A1 ATP2A2	6.15e-05	3	94	2	GO:0032470
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	RAET1G ULBP2 RAET1L	7.12e-05	18	94	3	GO:0002428
GeneOntologyBiologicalProcess	meiosis I cell cycle process	REC8 RAD51B TEX15 MLH3 MAEL SLX4	7.72e-05	155	94	6	GO:0061982
GeneOntologyBiologicalProcess	cell cycle process	REC8 RAD51B CHMP6 ATAD5 TOM1L1 BAZ1B TEX15 SPC24 MLH3 LLGL1 CRLF3 SMARCA2 MAEL TACC1 PLEC KLHL18 SLX4 DYNC1H1	7.78e-05	1441	94	18	GO:0022402
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	CHMP6 IFT172 CEP290 DNAH7 CCDC39 TBC1D32 LLGL1 AKAP9 ULK4 TACC1 CFAP69 DYNC1H1	1.04e-04	720	94	12	GO:0000226
GeneOntologyBiologicalProcess	nuclear division	REC8 RAD51B CHMP6 TOM1L1 BAZ1B TEX15 SPC24 MLH3 MAEL SLX4	1.14e-04	512	94	10	GO:0000280
GeneOntologyBiologicalProcess	cellular response to exogenous dsRNA	RAET1G ULBP2 RAET1L	1.33e-04	22	94	3	GO:0071360
GeneOntologyBiologicalProcess	piRNA processing	TEX15 MAEL TDRD6	1.33e-04	22	94	3	GO:0034587
GeneOntologyBiologicalProcess	axoneme assembly	DNAH7 CCDC39 TBC1D32 ULK4 CFAP69	1.42e-04	109	94	5	GO:0035082
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	RAET1G ULBP2 RAET1L	1.52e-04	23	94	3	GO:0019885
GeneOntologyBiologicalProcess	male meiotic nuclear division	REC8 TEX15 MLH3 MAEL	1.62e-04	60	94	4	GO:0007140
GeneOntologyBiologicalProcess	homologous chromosome pairing at meiosis	REC8 TEX15 MLH3 MAEL	1.62e-04	60	94	4	GO:0007129
GeneOntologyBiologicalProcess	male gamete generation	ZNF449 REC8 TSNAXIP1 SYNE1 KIAA0319L TEX15 MLH3 AKAP9 SMARCA2 MAEL TDRD6 CFAP69	1.76e-04	762	94	12	GO:0048232
GeneOntologyBiologicalProcess	organelle assembly	CHMP6 IFT172 SYNE1 CEP290 KIAA0319L RB1CC1 ARFIP2 DNAH7 CCDC39 TBC1D32 ULK4 PLEC CFAP69 ATP2A2 DYNC1H1	1.87e-04	1138	94	15	GO:0070925
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	RAET1G ULBP2 RAET1L	1.96e-04	25	94	3	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	RAET1G ULBP2 RAET1L	1.96e-04	25	94	3	GO:0002475
GeneOntologyBiologicalProcess	cytosol to endoplasmic reticulum transport	ATP2A2 ATP2A3	2.04e-04	5	94	2	GO:0046967
GeneOntologyBiologicalProcess	reciprocal meiotic recombination	REC8 RAD51B MLH3 SLX4	2.49e-04	67	94	4	GO:0007131
GeneOntologyBiologicalProcess	reciprocal homologous recombination	REC8 RAD51B MLH3 SLX4	2.49e-04	67	94	4	GO:0140527
GeneOntologyBiologicalProcess	chromosome segregation	REC8 CHMP6 BAZ1B TEX15 SPC24 MLH3 SMARCA2 MAEL DYNC1H1	2.72e-04	465	94	9	GO:0007059
GeneOntologyBiologicalProcess	cellular response to dsRNA	RAET1G ULBP2 RAET1L	2.76e-04	28	94	3	GO:0071359
GeneOntologyBiologicalProcess	positive regulation of response to tumor cell	RAET1G ULBP2 RAET1L	2.76e-04	28	94	3	GO:0002836
GeneOntologyBiologicalProcess	positive regulation of immune response to tumor cell	RAET1G ULBP2 RAET1L	2.76e-04	28	94	3	GO:0002839
GeneOntologyBiologicalProcess	endoplasmic reticulum calcium ion homeostasis	ATP2A1 ATP2A2 ATP2A3	3.07e-04	29	94	3	GO:0032469
GeneOntologyBiologicalProcess	regulation of cardiac conduction	ATP2A1 ATP2A2 ATP2A3	3.07e-04	29	94	3	GO:1903779
GeneOntologyBiologicalProcess	synaptonemal complex assembly	REC8 TEX15 MLH3	3.07e-04	29	94	3	GO:0007130
GeneOntologyBiologicalProcess	homologous recombination	REC8 RAD51B MLH3 SLX4	3.65e-04	74	94	4	GO:0035825
GeneOntologyBiologicalProcess	chromosome organization involved in meiotic cell cycle	REC8 TEX15 MLH3 MAEL	3.84e-04	75	94	4	GO:0070192
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity	RAET1G ULBP2 RAET1L VAV1	4.04e-04	76	94	4	GO:0042269
GeneOntologyBiologicalProcess	synaptonemal complex organization	REC8 TEX15 MLH3	4.13e-04	32	94	3	GO:0070193
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous antigen	RAET1G ULBP2 RAET1L	4.13e-04	32	94	3	GO:0019883
GeneOntologyBiologicalProcess	calcium ion import into sarcoplasmic reticulum	ATP2A1 ATP2A2	4.25e-04	7	94	2	GO:1990036
GeneOntologyBiologicalProcess	homologous chromosome segregation	REC8 TEX15 MLH3 MAEL	4.46e-04	78	94	4	GO:0045143
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated cytotoxicity	RAET1G ULBP2 RAET1L VAV1	4.68e-04	79	94	4	GO:0001912
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immunity	RAET1G ULBP2 RAET1L VAV1	4.91e-04	80	94	4	GO:0002715
GeneOntologyBiologicalProcess	nuclear migration	SYNE1 TACC1 DYNC1H1	4.95e-04	34	94	3	GO:0007097
GeneOntologyBiologicalProcess	regulation of macrophage activation	IL13 RAET1G ULBP2 RAET1L	5.15e-04	81	94	4	GO:0043030
GeneOntologyBiologicalProcess	microtubule bundle formation	DNAH7 CCDC39 TBC1D32 ULK4 CFAP69	5.32e-04	145	94	5	GO:0001578
GeneOntologyBiologicalProcess	inorganic ion homeostasis	IL13 CNNM2 CDH23 ITPR3 CNNM3 CNNM1 DMPK ATP2A1 ATP2A2 ATP2A3	5.37e-04	622	94	10	GO:0098771
GeneOntologyBiologicalProcess	positive regulation of natural killer cell activation	RAET1G ULBP2 RAET1L	5.40e-04	35	94	3	GO:0032816
GeneOntologyBiologicalProcess	regulation of cardiac muscle cell action potential involved in regulation of contraction	AKAP9 ATP2A2	5.65e-04	8	94	2	GO:0098909
GeneOntologyBiologicalProcess	regulation of cell killing	IL13 RAET1G ULBP2 RAET1L VAV1	5.67e-04	147	94	5	GO:0031341
GeneOntologyBiologicalProcess	spermatogenesis	ZNF449 REC8 TSNAXIP1 SYNE1 KIAA0319L TEX15 AKAP9 SMARCA2 MAEL TDRD6 CFAP69	5.67e-04	744	94	11	GO:0007283
GeneOntologyBiologicalProcess	positive regulation of lymphocyte mediated immunity	ATAD5 RAET1G ULBP2 RAET1L VAV1	6.21e-04	150	94	5	GO:0002708
GeneOntologyBiologicalProcess	positive regulation of cell killing	RAET1G ULBP2 RAET1L VAV1	7.04e-04	88	94	4	GO:0031343
GeneOntologyBiologicalProcess	regulation of blood circulation	DOCK4 AKAP9 DMPK ATP2A1 ATP2A2 ATP2A3 ALOX5	7.30e-04	326	94	7	GO:1903522
GeneOntologyBiologicalProcess	meiotic nuclear division	REC8 RAD51B TEX15 MLH3 MAEL SLX4	8.09e-04	240	94	6	GO:0140013
GeneOntologyBiologicalProcess	exocytosis	IL13 CHMP6 EFR3A LLGL1 CADPS MICAL3 SCRIB ATP2A2	8.27e-04	434	94	8	GO:0006887
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class I	RAET1G ULBP2 RAET1L	8.62e-04	41	94	3	GO:0002474
GeneOntologyBiologicalProcess	establishment of organelle localization	IL13 CHMP6 SYNE1 SPC24 LLGL1 CADPS TACC1 SCRIB DYNC1H1	8.64e-04	546	94	9	GO:0051656
GeneOntologyBiologicalProcess	positive regulation of T cell mediated cytotoxicity	RAET1G ULBP2 RAET1L	9.25e-04	42	94	3	GO:0001916
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	IFT172 SYNE1 CEP290 PARVB ARFIP2 DNAH7 CCDC39 TBC1D32 ULK4 CFAP69	9.50e-04	670	94	10	GO:0120031
GeneOntologyBiologicalProcess	cilium assembly	IFT172 SYNE1 CEP290 DNAH7 CCDC39 TBC1D32 ULK4 CFAP69	9.58e-04	444	94	8	GO:0060271
GeneOntologyBiologicalProcess	endomembrane system organization	TOR1AIP2 CHMP6 SYNE1 KIAA0319L AKAP9 HACE1 PLEC DMPK ATP2A2 COG4	9.72e-04	672	94	10	GO:0010256
GeneOntologyBiologicalProcess	regulation of cardiac muscle cell contraction	AKAP9 ATP2A1 ATP2A2	9.91e-04	43	94	3	GO:0086004
GeneOntologyBiologicalProcess	microtubule-based process	CHMP6 IFT172 CEP290 KIAA0319L DNAH7 CCDC39 TBC1D32 LLGL1 AKAP9 ULK4 TACC1 CFAP69 DYNC1H1	1.00e-03	1058	94	13	GO:0007017
GeneOntologyBiologicalProcess	nucleus localization	SYNE1 TACC1 DYNC1H1	1.06e-03	44	94	3	GO:0051647
GeneOntologyBiologicalProcess	cell projection assembly	IFT172 SYNE1 CEP290 PARVB ARFIP2 DNAH7 CCDC39 TBC1D32 ULK4 CFAP69	1.12e-03	685	94	10	GO:0030031
GeneOntologyBiologicalProcess	cardiac conduction	AKAP9 ATP2A1 ATP2A2 ATP2A3	1.14e-03	100	94	4	GO:0061337
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated immunity	ATAD5 RAET1G ULBP2 RAET1L VAV1	1.24e-03	175	94	5	GO:0002705
GeneOntologyBiologicalProcess	cilium movement	KIAA0319L DNAH7 CCDC39 ULK4 CFAP69 DYNC1H1	1.25e-03	261	94	6	GO:0003341
GeneOntologyBiologicalProcess	positive regulation of type II interferon production	RAET1G ULBP2 RAET1L SCRIB	1.27e-03	103	94	4	GO:0032729
GeneOntologyBiologicalProcess	intracellular calcium ion homeostasis	IL13 CDH23 ITPR3 DMPK ATP2A1 ATP2A2 ATP2A3	1.28e-03	359	94	7	GO:0006874
GeneOntologyBiologicalProcess	natural killer cell mediated cytotoxicity	RAET1G ULBP2 RAET1L VAV1	1.36e-03	105	94	4	GO:0042267
GeneOntologyBiologicalProcess	monoatomic cation homeostasis	IL13 CNNM2 CDH23 ITPR3 CNNM3 CNNM1 DMPK ATP2A1 ATP2A2 ATP2A3	1.39e-03	705	94	10	GO:0055080
GeneOntologyBiologicalProcess	meiotic cell cycle process	REC8 RAD51B TEX15 MLH3 MAEL SLX4	1.43e-03	268	94	6	GO:1903046
GeneOntologyBiologicalProcess	regulation of immune response to tumor cell	RAET1G ULBP2 RAET1L	1.45e-03	49	94	3	GO:0002837
GeneOntologyBiologicalProcess	cilium organization	IFT172 SYNE1 CEP290 DNAH7 CCDC39 TBC1D32 ULK4 CFAP69	1.49e-03	476	94	8	GO:0044782
GeneOntologyBiologicalProcess	regulation of response to tumor cell	RAET1G ULBP2 RAET1L	1.54e-03	50	94	3	GO:0002834
GeneOntologyBiologicalProcess	maintenance of organelle location	AKAP9 ATP2A1	1.55e-03	13	94	2	GO:0051657
GeneOntologyBiologicalProcess	natural killer cell mediated immunity	RAET1G ULBP2 RAET1L VAV1	1.56e-03	109	94	4	GO:0002228
GeneOntologyBiologicalProcess	monoatomic ion homeostasis	IL13 CNNM2 CDH23 ITPR3 CNNM3 CNNM1 DMPK ATP2A1 ATP2A2 ATP2A3	1.58e-03	717	94	10	GO:0050801
GeneOntologyBiologicalProcess	gamete generation	ZNF449 REC8 TSNAXIP1 SYNE1 KIAA0319L TEX15 MLH3 AKAP9 SMARCA2 MAEL TDRD6 CFAP69	1.66e-03	982	94	12	GO:0007276
GeneOntologyBiologicalProcess	regulation of striated muscle contraction	AKAP9 DMPK ATP2A1 ATP2A2	1.67e-03	111	94	4	GO:0006942
GeneOntologyBiologicalProcess	mitotic cell cycle process	RAD51B CHMP6 ATAD5 TOM1L1 BAZ1B SPC24 CRLF3 SMARCA2 TACC1 KLHL18 DYNC1H1	1.73e-03	854	94	11	GO:1903047
GeneOntologyBiologicalProcess	negative regulation of receptor binding	ATP2A2 ATP2A3	1.80e-03	14	94	2	GO:1900121
GeneOntologyBiologicalProcess	regulation of T cell mediated cytotoxicity	RAET1G ULBP2 RAET1L	1.82e-03	53	94	3	GO:0001914
GeneOntologyBiologicalProcess	regulation of actin filament-based movement	AKAP9 ATP2A1 ATP2A2	1.82e-03	53	94	3	GO:1903115
GeneOntologyBiologicalProcess	positive regulation of lymphocyte activation	IL13 ATAD5 RAET1G SMARCA2 ULBP2 RAET1L VAV1	1.90e-03	385	94	7	GO:0051251
GeneOntologyBiologicalProcess	regulation of lymphocyte activation	IL13 ATAD5 RAET1G GLMN SMARCA2 ULBP2 RAET1L SCRIB VAV1	1.94e-03	614	94	9	GO:0051249
GeneOntologyBiologicalProcess	calcium ion homeostasis	IL13 CDH23 ITPR3 DMPK ATP2A1 ATP2A2 ATP2A3	2.02e-03	389	94	7	GO:0055074
GeneOntologyBiologicalProcess	response to exogenous dsRNA	RAET1G ULBP2 RAET1L	2.03e-03	55	94	3	GO:0043330
GeneOntologyBiologicalProcess	immune response to tumor cell	RAET1G ULBP2 RAET1L	2.13e-03	56	94	3	GO:0002418
GeneOntologyBiologicalProcess	mitotic cell cycle	RAD51B CHMP6 ATAD5 TOM1L1 BAZ1B SPC24 CRLF3 SMARCA2 TACC1 SCRIB KLHL18 DYNC1H1	2.17e-03	1014	94	12	GO:0000278
GeneOntologyCellularComponent	platelet dense tubular network membrane	ITPR3 ATP2A1 ATP2A2 ATP2A3	5.39e-08	9	97	4	GO:0031095
GeneOntologyCellularComponent	platelet dense tubular network	ITPR3 ATP2A1 ATP2A2 ATP2A3	1.40e-07	11	97	4	GO:0031094
GeneOntologyCellularComponent	sarcoplasm	ITPR3 PLEC DMPK ATP2A1 ATP2A2 ATP2A3	1.52e-05	114	97	6	GO:0016528
GeneOntologyCellularComponent	sarcoplasmic reticulum	ITPR3 DMPK ATP2A1 ATP2A2 ATP2A3	5.60e-05	88	97	5	GO:0016529
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	DMPK ATP2A1 ATP2A2 ATP2A3	5.61e-05	45	97	4	GO:0033017
GeneOntologyCellularComponent	cluster of actin-based cell projections	DOCK4 VEZT CDH23 ITPR3 PLEC SLC23A1	6.07e-04	223	97	6	GO:0098862
GeneOntologyCellularComponent	myelin sheath abaxonal region	LLGL1 SCRIB	7.51e-04	9	97	2	GO:0035748
GeneOntologyCellularComponent	nuclear outer membrane	SYNE1 ITPR3 DMPK	8.45e-04	40	97	3	GO:0005640
GeneOntologyCellularComponent	extrinsic component of postsynaptic density membrane	AKAP9 SCRIB	9.36e-04	10	97	2	GO:0099147
GeneOntologyCellularComponent	nuclear envelope	TOR1AIP2 CHMP6 SYNE1 RB1CC1 ITPR3 DMPK ATP2A3 ALOX5 DYNC1H1	1.18e-03	560	97	9	GO:0005635
GeneOntologyCellularComponent	nuclear membrane	TOR1AIP2 SYNE1 RB1CC1 ITPR3 DMPK ATP2A3 ALOX5	1.21e-03	349	97	7	GO:0031965
GeneOntologyCellularComponent	extrinsic component of postsynaptic specialization membrane	AKAP9 SCRIB	1.36e-03	12	97	2	GO:0098892
GeneOntologyCellularComponent	organelle outer membrane	SYNE1 TUFM ITPR3 PLEC DMPK MIEF2	1.92e-03	279	97	6	GO:0031968
GeneOntologyCellularComponent	outer membrane	SYNE1 TUFM ITPR3 PLEC DMPK MIEF2	1.99e-03	281	97	6	GO:0019867
Domain	P-type_ATPase_IIA	ATP2A1 ATP2A2 ATP2A3	1.32e-07	3	96	3	IPR005782
Domain	DUF21	CNNM2 CNNM3 CNNM1	5.24e-07	4	96	3	IPR002550
Domain	DUF21	CNNM2 CNNM3 CNNM1	5.24e-07	4	96	3	PF01595
Domain	Hydrolase_3	ATP2A1 ATP2A2 ATP2A3	1.54e-05	10	96	3	PF08282
Domain	CH	SYNE1 PARVB MICAL3 PLEC VAV1	2.09e-05	65	96	5	SM00033
Domain	CH	SYNE1 PARVB MICAL3 PLEC VAV1	3.00e-05	70	96	5	PF00307
Domain	-	SYNE1 PARVB MICAL3 PLEC VAV1	3.22e-05	71	96	5	1.10.418.10
Domain	CH	SYNE1 PARVB MICAL3 PLEC VAV1	3.68e-05	73	96	5	PS50021
Domain	CH-domain	SYNE1 PARVB MICAL3 PLEC VAV1	4.19e-05	75	96	5	IPR001715
Domain	-	ATP2A1 ATP2A2 ATP2A3	7.02e-05	16	96	3	1.20.1110.10
Domain	ATPase_P-typ_TM_dom	ATP2A1 ATP2A2 ATP2A3	7.02e-05	16	96	3	IPR023298
Domain	ATPase_P-typ_cation-transptr_C	ATP2A1 ATP2A2 ATP2A3	8.49e-05	17	96	3	IPR006068
Domain	Cation_ATPase_C	ATP2A1 ATP2A2 ATP2A3	8.49e-05	17	96	3	PF00689
Domain	Cation_ATPase_N	ATP2A1 ATP2A2 ATP2A3	1.02e-04	18	96	3	PF00690
Domain	Cation_ATPase_N	ATP2A1 ATP2A2 ATP2A3	1.02e-04	18	96	3	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP2A1 ATP2A2 ATP2A3	1.20e-04	19	96	3	IPR004014
Domain	CBS_dom	CNNM2 CNNM3 CNNM1	1.41e-04	20	96	3	IPR000644
Domain	CBS	CNNM2 CNNM3 CNNM1	1.41e-04	20	96	3	PF00571
Domain	CBS	CNNM2 CNNM3 CNNM1	1.41e-04	20	96	3	PS51371
Domain	MLK1/MLK2/MLK4	MAP3K9 MAP3K21	1.56e-04	4	96	2	IPR016231
Domain	MAP3K10	MAP3K9 MAP3K21	1.56e-04	4	96	2	IPR015785
Domain	MHC_I	RAET1G ULBP2 RAET1L	1.64e-04	21	96	3	PF00129
Domain	MHC_I_a_a1/a2	RAET1G ULBP2 RAET1L	1.64e-04	21	96	3	IPR001039
Domain	-	RAET1G ULBP2 RAET1L	2.46e-04	24	96	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	RAET1G ULBP2 RAET1L	2.46e-04	24	96	3	IPR011161
Domain	-	ATP2A1 ATP2A2 ATP2A3	5.86e-04	32	96	3	3.40.1110.10
Domain	-	ATP2A1 ATP2A2 ATP2A3	5.86e-04	32	96	3	2.70.150.10
Domain	Ubox	TRIM21 UBE4A	7.17e-04	8	96	2	SM00504
Domain	ATPase_P-typ_cyto_domN	ATP2A1 ATP2A2 ATP2A3	7.64e-04	35	96	3	IPR023299
Domain	P_typ_ATPase	ATP2A1 ATP2A2 ATP2A3	8.31e-04	36	96	3	IPR001757
Domain	ATPase_P-typ_P_site	ATP2A1 ATP2A2 ATP2A3	8.31e-04	36	96	3	IPR018303
Domain	ATPASE_E1_E2	ATP2A1 ATP2A2 ATP2A3	8.31e-04	36	96	3	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP2A1 ATP2A2 ATP2A3	9.01e-04	37	96	3	IPR008250
Domain	E1-E2_ATPase	ATP2A1 ATP2A2 ATP2A3	9.01e-04	37	96	3	PF00122
Domain	MHC_I/II-like_Ag-recog	RAET1G ULBP2 RAET1L	9.74e-04	38	96	3	IPR011162
Domain	Ubox_domain	TRIM21 UBE4A	1.15e-03	10	96	2	IPR003613
Domain	Dynein_heavy_chain_D4_dom	DNAH7 DYNC1H1	2.29e-03	14	96	2	IPR024317
Domain	Dynein_HC_stalk	DNAH7 DYNC1H1	2.29e-03	14	96	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH7 DYNC1H1	2.29e-03	14	96	2	IPR013602
Domain	DHC_N2	DNAH7 DYNC1H1	2.29e-03	14	96	2	PF08393
Domain	MT	DNAH7 DYNC1H1	2.29e-03	14	96	2	PF12777
Domain	AAA_8	DNAH7 DYNC1H1	2.29e-03	14	96	2	PF12780
Domain	DHC_fam	DNAH7 DYNC1H1	2.63e-03	15	96	2	IPR026983
Domain	Dynein_heavy_dom	DNAH7 DYNC1H1	2.63e-03	15	96	2	IPR004273
Domain	Dynein_heavy	DNAH7 DYNC1H1	2.63e-03	15	96	2	PF03028
Domain	IG_MHC	RAET1G ULBP2 RAET1L	3.64e-03	60	96	3	PS00290
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA	ATP2A1 ATP2A2 ATP2A3	7.02e-06	8	72	3	M47955
Pathway	REACTOME_ION_HOMEOSTASIS	ITPR3 DMPK ATP2A1 ATP2A2 ATP2A3	7.86e-06	54	72	5	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	ITPR3 DMPK ATP2A1 ATP2A2 ATP2A3	7.86e-06	54	72	5	MM15202
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ITPR3 ATP2A1 ATP2A2 ATP2A3	1.00e-05	27	72	4	MM15053
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ITPR3 ATP2A1 ATP2A2 ATP2A3	1.17e-05	28	72	4	M924
Pathway	REACTOME_CARDIAC_CONDUCTION	ITPR3 AKAP9 DMPK ATP2A1 ATP2A2 ATP2A3	1.39e-05	103	72	6	MM15196
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2A1 ATP2A2 ATP2A3	2.72e-05	12	72	3	M27326
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2A1 ATP2A2 ATP2A3	4.47e-05	14	72	3	MM15052
Pathway	REACTOME_CARDIAC_CONDUCTION	ITPR3 AKAP9 DMPK ATP2A1 ATP2A2 ATP2A3	5.20e-05	130	72	6	M27454
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	ATP2A1 ATP2A2 ATP2A3	9.87e-05	18	72	3	M614
Pathway	REACTOME_MUSCLE_CONTRACTION	ITPR3 AKAP9 DMPK ATP2A1 ATP2A2 ATP2A3	1.94e-04	165	72	6	MM15026
Pathway	WP_ALZHEIMERS_DISEASE	ITPR3 ATP2A1 ATP2A2 ATP2A3	5.50e-04	74	72	4	MM15962
Pathway	REACTOME_MUSCLE_CONTRACTION	ITPR3 AKAP9 DMPK ATP2A1 ATP2A2 ATP2A3	5.87e-04	203	72	6	M5485
Pathway	REACTOME_PLATELET_HOMEOSTASIS	ITPR3 ATP2A1 ATP2A2 ATP2A3	6.08e-04	76	72	4	MM15051
Pathway	REACTOME_INTERLEUKIN_18_SIGNALING	IL13 ALOX5	7.06e-04	8	72	2	M27878
Pathway	REACTOME_PLATELET_HOMEOSTASIS	ITPR3 ATP2A1 ATP2A2 ATP2A3	9.69e-04	86	72	4	M916
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	ITPR3 ATP2A1 ATP2A2 ATP2A3	4.46e-09	8	100	4	19033399
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TOR1AIP2 PPP4R1 VEZT ATAD5 CEP290 RB1CC1 ITPR3 EFR3A CNNM3 GLMN CNNM1 AKAP9 CRLF3 EFR3B MICAL3 SCRIB ATP2A2	7.88e-09	1049	100	17	27880917
Pubmed	Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.	RAET1G ULBP2 RAET1L	2.31e-08	3	100	3	25212604
Pubmed	The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) Ca2+ pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors.	ATP2A1 ATP2A2 ATP2A3	2.31e-08	3	100	3	16410239
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	TOR1AIP2 VEZT ATAD5 SYNE1 BAZ1B RB1CC1 AKAP12 ITPR3 EFR3A CNNM3 UBE4A LLGL1 AKAP9 DNAJC28 SMU1 EFR3B TACC1 SCRIB ATP2A2	4.24e-08	1487	100	19	33957083
Pubmed	Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms.	RAET1G ULBP2 RAET1L	9.21e-08	4	100	3	20166740
Pubmed	The nongastric H+-K+-ATPases: molecular and functional properties.	ATP2A1 ATP2A2 ATP2A3	9.21e-08	4	100	3	10362770
Pubmed	Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules.	RAET1G ULBP2 RAET1L	9.21e-08	4	100	3	8882725
Pubmed	Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.	RAET1G ULBP2 RAET1L	9.21e-08	4	100	3	12421908
Pubmed	NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.	RAET1G ULBP2 RAET1L	9.21e-08	4	100	3	12756263
Pubmed	Molecular cloning and characterization of the mouse Acdp gene family.	CNNM2 CNNM3 CNNM1	9.21e-08	4	100	3	14723793
Pubmed	Purification, crystallization and preliminary crystallographic analysis of the CBS pair of the human metal transporter CNNM4.	CNNM2 CNNM3 CNNM1	9.21e-08	4	100	3	21393841
Pubmed	Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.	ATP2A1 ATP2A2 ATP2A3	9.21e-08	4	100	3	25110346
Pubmed	Murine NKG2D ligands: "double, double toil and trouble".	RAET1G ULBP2 RAET1L	9.21e-08	4	100	3	19081632
Pubmed	Molecular cloning and characterization of a novel gene family of four ancient conserved domain proteins (ACDP).	CNNM2 CNNM3 CNNM1	9.21e-08	4	100	3	12657465
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	ZKSCAN8 TRIM21 RB1CC1 TUFM AKAP12 EPM2AIP1 ITPR3 MICAL3 PLEC DYNC1H1	9.45e-08	360	100	10	33111431
Pubmed	MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.	RAET1G ULBP2 RAET1L	2.30e-07	5	100	3	24572784
Pubmed	Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain.	RAET1G ULBP2 RAET1L	2.30e-07	5	100	3	8982867
Pubmed	The ER-Localized Transmembrane Protein EPG-3/VMP1 Regulates SERCA Activity to Control ER-Isolation Membrane Contacts for Autophagosome Formation.	RB1CC1 ATP2A1 ATP2A2 ATP2A3	4.52e-07	22	100	4	28890335
Pubmed	Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D.	RAET1G ULBP2 RAET1L	4.58e-07	6	100	3	11825567
Pubmed	Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations.	RAET1G ULBP2 RAET1L	4.58e-07	6	100	3	20219610
Pubmed	The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.	RAET1G ULBP2 RAET1L	4.58e-07	6	100	3	20976056
Pubmed	Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.	RAET1G ULBP2 RAET1L	4.58e-07	6	100	3	10894171
Pubmed	Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais.	RAET1G ULBP2 RAET1L	4.58e-07	6	100	3	19688209
Pubmed	Ligands for murine NKG2D display heterogeneous binding behavior.	RAET1G ULBP2 RAET1L	4.58e-07	6	100	3	11857333
Pubmed	The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.	RAET1G ULBP2 RAET1L	8.01e-07	7	100	3	16831899
Pubmed	Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase.	RAET1G ULBP2 RAET1L	8.01e-07	7	100	3	20870941
Pubmed	Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.	RAET1G ULBP2 RAET1L	8.01e-07	7	100	3	26151313
Pubmed	NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.	RAET1G ULBP2 RAET1L	8.01e-07	7	100	3	30787931
Pubmed	Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.	RAET1G ULBP2 RAET1L	8.01e-07	7	100	3	12370332
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	ATP2A1 ATP2A2 ATP2A3	8.01e-07	7	100	3	24786561
Pubmed	NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.	RAET1G ULBP2 RAET1L	8.01e-07	7	100	3	25583577
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	TOR1AIP2 CHMP6 VEZT KIAA0319L AKAP12 EFR3A CNNM3 LLGL1 EFR3B TACC1	1.02e-06	467	100	10	30194290
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2A1 ATP2A2 ATP2A3	1.28e-06	8	100	3	10951186
Pubmed	A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.	RAET1G ULBP2 RAET1L	1.28e-06	8	100	3	12645935
Pubmed	Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides.	ATP2A1 ATP2A2 ATP2A3	1.28e-06	8	100	3	27923914
Pubmed	A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.	ATP2A1 ATP2A2 ATP2A3	1.91e-06	9	100	3	25640239
Pubmed	Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells.	RAET1G ULBP2 RAET1L	1.91e-06	9	100	3	23136011
Pubmed	Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor.	RAET1G ULBP2 RAET1L	1.91e-06	9	100	3	14764662
Pubmed	A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.	RAET1G ULBP2 RAET1L	2.73e-06	10	100	3	11827464
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	TUFM AKAP9 PLEC ATP2A1 DYNC1H1	2.79e-06	76	100	5	27542412
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 IFT172 SYNE1 EPM2AIP1 AKAP9 CADPS MICAL3 SCRIB DYNC1H1	2.80e-06	407	100	9	12693553
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	SYNE1 TRIM21 TUFM ITPR3 HACE1 PLEC ALOX5	2.98e-06	214	100	7	22199357
Pubmed	Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.	RAET1G ULBP2 RAET1L	3.74e-06	11	100	3	26656785
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PPP4R1 REPS1 IFT172 SYNE1 CEP290 KIAA0319L PARVB UBE4A CADPS SCRIB PLEC ATP2A2 COG4 SLX4 DYNC1H1	4.02e-06	1285	100	15	35914814
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	ITPR3 ATP2A1 ATP2A2 ATP2A3	4.41e-06	38	100	4	30786075
Pubmed	USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c.	BAZ1B TUFM PLEC ATP2A2 DYNC1H1	6.43e-06	90	100	5	35654790
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CHMP6 SYNE1 CEP290 BAZ1B RB1CC1 TUFM ITPR3 CNNM3 SMU1 SCRIB PLEC ATP2A2 DYNC1H1	7.73e-06	1024	100	13	24711643
Pubmed	Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice.	ATP2A1 ATP2A2	8.18e-06	2	100	2	12556521
Pubmed	Scribble, Lgl1, and myosin II form a complex in vivo to promote directed cell migration.	LLGL1 SCRIB	8.18e-06	2	100	2	32697665
Pubmed	Regulation of SERCA pumps expression in diabetes.	ATP2A2 ATP2A3	8.18e-06	2	100	2	25270119
Pubmed	Atypical fast SERCA1a protein expression in slow myofibers and differential S-nitrosylation prevented by exercise during long term bed rest.	ATP2A1 ATP2A2	8.18e-06	2	100	2	19644701
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles.	ATP2A1 ATP2A2	8.18e-06	2	100	2	14638697
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology.	ATP2A1 ATP2A2	8.18e-06	2	100	2	10603953
Pubmed	Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight.	ATP2A1 ATP2A2	8.18e-06	2	100	2	34769190
Pubmed	Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.	ATP2A2 ATP2A3	8.18e-06	2	100	2	18295663
Pubmed	Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.	ATP2A2 ATP2A3	8.18e-06	2	100	2	19650915
Pubmed	Training induced decrease in oxygen cost of cycling is accompanied by down-regulation of SERCA expression in human vastus lateralis muscle.	ATP2A1 ATP2A2	8.18e-06	2	100	2	18953100
Pubmed	The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg2+ efflux activity.	CNNM2 CNNM3	8.18e-06	2	100	2	30341174
Pubmed	SERCA overexpression reduces hydroxyl radical injury in murine myocardium.	ATP2A1 ATP2A2	8.18e-06	2	100	2	16798816
Pubmed	Mechanisms of control of the free Ca2+ concentration in the endoplasmic reticulum of mouse pancreatic β-cells: interplay with cell metabolism and [Ca2+]c and role of SERCA2b and SERCA3.	ATP2A2 ATP2A3	8.18e-06	2	100	2	21885870
Pubmed	Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.	ATP2A2 ATP2A3	8.18e-06	2	100	2	19962989
Pubmed	Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling.	IL13 ALOX5	8.18e-06	2	100	2	16849505
Pubmed	Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.	ATP2A1 ATP2A2	8.18e-06	2	100	2	12975374
Pubmed	Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm.	ATP2A1 ATP2A2	8.18e-06	2	100	2	15718407
Pubmed	SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis.	ATP2A1 ATP2A2	8.18e-06	2	100	2	11402072
Pubmed	Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration.	AKAP12 EFR3A LLGL1 SCRIB	9.57e-06	46	100	4	35022314
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DOCK4 SYNE1 EPM2AIP1 AKAP9 KLHL18	1.13e-05	101	100	5	9872452
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KIAA0319L CDH23 MAP3K21 SLX4 FBN3	1.50e-05	107	100	5	11347906
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	CNNM2 PCDHGA4 EFR3A CNNM3 CNNM1 LLGL1 EFR3B ATP2A2	2.31e-05	405	100	8	38187761
Pubmed	EFR3s are palmitoylated plasma membrane proteins that control responsiveness to G-protein-coupled receptors.	EFR3A EFR3B	2.45e-05	3	100	2	25380825
Pubmed	Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.	ATP2A1 ATP2A2	2.45e-05	3	100	2	27055500
Pubmed	Regulation of asymmetric cell division and polarity by Scribble is not required for humoral immunity.	LLGL1 SCRIB	2.45e-05	3	100	2	23653213
Pubmed	Sarcoplasmic reticulum Ca2+ ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart.	ATP2A1 ATP2A2	2.45e-05	3	100	2	25615793
Pubmed	Modulation of endoplasmic reticulum calcium pump by Bcl-2.	ATP2A2 ATP2A3	2.45e-05	3	100	2	9788433
Pubmed	Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis.	ATP2A2 ATP2A3	2.45e-05	3	100	2	16973504
Pubmed	Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.	ATP2A2 ATP2A3	2.45e-05	3	100	2	19419309
Pubmed	Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.	ATP2A1 ATP2A2	2.45e-05	3	100	2	11526231
Pubmed	Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3.	ATP2A2 ATP2A3	2.45e-05	3	100	2	15161756
Pubmed	Differential regulation of Dlg1, Scrib, and Lgl1 expression in a transgenic mouse model of ocular cancer.	LLGL1 SCRIB	2.45e-05	3	100	2	19098995
Pubmed	Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.	ATP2A1 ATP2A2	2.45e-05	3	100	2	15972723
Pubmed	Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent.	IL13 ALOX5	2.45e-05	3	100	2	16339565
Pubmed	Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.	ATP2A1 ATP2A2	2.45e-05	3	100	2	16754798
Pubmed	Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.	ATP2A1 ATP2A2	2.45e-05	3	100	2	9038922
Pubmed	Specific effects of endurance and sprint training on protein expression of calsequestrin and SERCA in mouse skeletal muscle.	ATP2A1 ATP2A2	2.45e-05	3	100	2	22466636
Pubmed	Regulation of error-prone translesion synthesis by Spartan/C1orf124.	TUFM AKAP12 ATP2A2 DYNC1H1	2.59e-05	59	100	4	23254330
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF20 NBPF19 NBPF10	2.95e-05	21	100	3	16079250
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	REPS1 AKAP12 EFR3A LLGL1 EFR3B MICAL3 SCRIB MAP3K21 ATP2A2 DYNC1H1	3.83e-05	708	100	10	39231216
Pubmed	Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs).	ATP2A1 ATP2A2	4.89e-05	4	100	2	12032137
Pubmed	Nesprin-1α-Dependent Microtubule Nucleation from the Nuclear Envelope via Akap450 Is Necessary for Nuclear Positioning in Muscle Cells.	SYNE1 AKAP9	4.89e-05	4	100	2	28966089
Pubmed	Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle.	ATP2A1 ATP2A2	4.89e-05	4	100	2	12074580
Pubmed	Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart.	ATP2A1 ATP2A2	4.89e-05	4	100	2	9295312
Pubmed	TMEM203 Is a Novel Regulator of Intracellular Calcium Homeostasis and Is Required for Spermatogenesis.	ITPR3 ATP2A2	4.89e-05	4	100	2	25996873
Pubmed	Regulation of the hDlg/hScrib/Hugl-1 tumour suppressor complex.	LLGL1 SCRIB	4.89e-05	4	100	2	18793635
Pubmed	Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.	RAET1G ULBP2	4.89e-05	4	100	2	19424970
Pubmed	SERCA1a can functionally substitute for SERCA2a in the heart.	ATP2A1 ATP2A2	4.89e-05	4	100	2	9887021
Pubmed	Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.	ATP2A1 ATP2A2	4.89e-05	4	100	2	10555147
Pubmed	SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets.	ATP2A2 ATP2A3	4.89e-05	4	100	2	18068335
Pubmed	FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.	TOR1AIP2 PGS1 VEZT ITPR3 CNNM3 UBE4A TACC1 COG4	6.39e-05	468	100	8	31056421
Pubmed	Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.	TOM1L1 LLGL1 MIEF2	6.42e-05	27	100	3	17273973
Interaction	ARF6 interactions	TOR1AIP2 ACAP1 VEZT KIAA0319L ARFIP2 DNAH7 AKAP12 EFR3A CNNM3 LLGL1 EFR3B ATP2A1 DYNC1H1	5.62e-06	584	99	13	int:ARF6
Interaction	LMAN1 interactions	TOR1AIP2 GINM1 VEZT RB1CC1 TUFM ITPR3 GLMN LLGL1 TACC1 ATP2A1 ATP2A2	1.09e-05	441	99	11	int:LMAN1
Interaction	GJD3 interactions	TOR1AIP2 VEZT SYNE1 KIAA0319L ITPR3 EFR3A LLGL1 EFR3B TACC1 SCRIB COG4	1.43e-05	454	99	11	int:GJD3
Interaction	DIRAS3 interactions	EFR3A CNNM3 GLMN LLGL1 EFR3B MAP3K9 SCRIB MAP3K21	4.53e-05	262	99	8	int:DIRAS3
Interaction	ATOH1 interactions	TUFM AKAP9 PLEC ATP2A1 DYNC1H1	4.64e-05	80	99	5	int:ATOH1
Interaction	STX4 interactions	TOR1AIP2 VEZT SYNE1 ITPR3 CNNM3 LLGL1 EFR3B MICAL3 TACC1 SCRIB	4.86e-05	428	99	10	int:STX4
Cytoband	Ensembl 112 genes in cytogenetic band chr6q25	GINM1 SYNE1 RAET1G UST AKAP12 ULBP2 RAET1L	7.90e-08	164	100	7	chr6q25
Cytoband	6q25.1	GINM1 UST RAET1L	8.00e-05	38	100	3	6q25.1
Cytoband	6q25	SYNE1 ULBP2	3.06e-04	12	100	2	6q25
GeneFamily	ATPases Ca2+ transporting	ATP2A1 ATP2A2 ATP2A3	3.34e-06	9	63	3	1209
GeneFamily	Neuroblastoma breakpoint family	NBPF20 NBPF19 NBPF10	6.79e-05	23	63	3	662
GeneFamily	Membrane associated guanylate kinases\|PDZ domain containing\|Scribble complex	LLGL1 SCRIB	7.14e-05	4	63	2	1224
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	IFT172 CEP290	2.40e-03	21	63	2	980
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K9 MAP3K21	3.14e-03	24	63	2	654
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP12 AKAP9	4.57e-03	29	63	2	396
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 SYNE1 CEP290 DNAH7 CCDC39 AKAP9 ULK4 CFAP69	1.54e-08	197	100	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 SYNE1 DNAH7 CCDC39 ULK4 CFAP69	5.06e-06	194	100	6	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 SYNE1 DNAH7 CCDC39 AKAP9 CFAP69	5.53e-06	197	100	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 SYNE1 DNAH7 CCDC39 AKAP9 CFAP69	5.53e-06	197	100	6	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 SYNE1 DNAH7 CCDC39 AKAP9 CFAP69	5.53e-06	197	100	6	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 SYNE1 DNAH7 CCDC39 AKAP9 CFAP69	5.53e-06	197	100	6	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf\|Cerebellum / BrainAtlas - Mouse McCarroll V32	TEX15 TRPV3 TDRD6 SLC23A1	1.24e-05	63	100	4	83e1c91f830aadaf13e13254ce30189fd434bcc9
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	TEX15 TRPV3 TDRD6 SLC23A1	1.24e-05	63	100	4	f2532b1aa117eea550f0ae0b599780c4fe621407
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1\|Cerebellum / BrainAtlas - Mouse McCarroll V32	TEX15 TRPV3 TDRD6 SLC23A1	1.24e-05	63	100	4	0643435edf3280daf38c950e5bec287a9d5cb517
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	TEX15 TRPV3 TDRD6 SLC23A1	1.24e-05	63	100	4	71c3afda6534401320791b714e3e2fe83094c914
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IL13 CADPS TDRD6 ALOX5 VAV1	3.16e-05	161	100	5	c54010d88f1ecb6e0235bb66084876a4d5bf1ecd
ToppCell	droplet-Liver-Npc-21m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 TEX15 IGFLR1 CCR4 ATP2A3	3.55e-05	165	100	5	6708beb0e8094f30cf5cd812e6a67a6db004a580
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPM2AIP1 CNNM1 CADPS KANK4 TRPV3	3.76e-05	167	100	5	55c3c68af269fcf40f2b080ae4489523609ad388
ToppCell	droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC39 EFR3B KANK4 B4GALNT2 CFAP69	3.76e-05	167	100	5	a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCell	control-Myeloid-Mast_cell\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PARVB IGFLR1 AKAP12 CADPS ALOX5	4.32e-05	172	100	5	c1c99e6732234a6649a79610e99390db0c8f19b0
ToppCell	ILEUM-inflamed-(4)_Mast\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IL13 AKAP12 CADPS ZSWIM4 ALOX5	4.32e-05	172	100	5	be82f749f4b1049ae8832facc052082cf5463c11
ToppCell	ILEUM-inflamed-(4)_Mast_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IL13 AKAP12 CADPS ZSWIM4 ALOX5	4.32e-05	172	100	5	7185b28282412f3a464b2a8ad5605475a1a31358
ToppCell	NS-control-d_0-4-Myeloid-Mast_cell\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PARVB IGFLR1 AKAP12 CADPS ALOX5	4.57e-05	174	100	5	2d1f5c17b1551f32f49618ec1bf68eafbfd02ace
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UST CCDC39 ITPR3 B4GALNT2 DMPK	4.70e-05	175	100	5	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP290 CADPS ULK4 ATP2A2 ATP2A3	5.09e-05	178	100	5	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA4 ADAMTS12 ATP2A3 ALOX5 VAV1	5.09e-05	178	100	5	09a215a0d6e98e4bb920cabda12af08ff4de3c98
ToppCell	COVID-19-kidney-Bcells\|kidney / Disease (COVID-19 only), tissue and cell type	ACAP1 UST ATP2A3 ALOX5 VAV1	5.37e-05	180	100	5	5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	REC8 C10orf67 SPC24 TBC1D32 SCRIB	5.66e-05	182	100	5	e6968e0bd9cef92052d04ac54e2dd746b37623f6
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TSNAXIP1 C10orf67 DNAH7 CCDC39 CFAP69	6.11e-05	185	100	5	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	PARVB SNX25 TRPV3 MICAL3 ATP2A3	6.11e-05	185	100	5	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 TSC22D3 GUCY2C TRPV3 MICAL3	6.27e-05	186	100	5	1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 TSC22D3 GUCY2C TRPV3 MICAL3	6.27e-05	186	100	5	f1366638edaecad5cad6367440f4c693513bed7e
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TSNAXIP1 C10orf67 DNAH7 CCDC39 CFAP69	6.27e-05	186	100	5	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Mast_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL13 TEX15 AKAP12 CADPS ALOX5	6.76e-05	189	100	5	7bc6e152fb4fe5cd6db9407929c15843a5d8f8c4
ToppCell	facs-Lung-nan-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSNAXIP1 IL13 CCDC39 ULK4 CFAP69	6.93e-05	190	100	5	e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1
ToppCell	facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSNAXIP1 IL13 CCDC39 ULK4 CFAP69	6.93e-05	190	100	5	fe844559b95832845d2e8d3ab4b57e3d558bc372
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK4 AKAP12 ADAMTS12 MICAL3 TACC1	7.11e-05	191	100	5	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	IL13 ACAP1 ATP2A3 ALOX5 VAV1	7.11e-05	191	100	5	14b11244c330cc4fe897253aaaf0df80caa01a55
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 ZKSCAN8 AKAP12 TBC1D32 AKAP9	7.46e-05	193	100	5	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 CDH23 UST ALOX5 VAV1	7.83e-05	195	100	5	62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP9 CADPS ATP2A2 ATP2A3 DYNC1H1	7.83e-05	195	100	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP9 CADPS ATP2A2 ATP2A3 DYNC1H1	7.83e-05	195	100	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	DOCK4 PGS1 CDH23 NBPF19 VAV1	7.83e-05	195	100	5	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	Biopsy_Other_PF-Immune-Mast_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IL13 TEX15 CADPS ATP2A3 ALOX5	8.42e-05	198	100	5	9f015553598d4c6774b2f9759e8c0f0f93e51c67
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-3\|TCGA-Thymus / Sample_Type by Project: Shred V9	DOCK4 PCDHGA4 GUCY2C TRIM17	8.58e-05	103	100	4	91fe062dcadd12fdb04fa4593a794c57f3f0411d
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	CEP290 RB1CC1 CCDC39 AKAP9 SMARCA2	8.62e-05	199	100	5	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PARVB CADPS ATP2A3 ALOX5 VAV1	8.83e-05	200	100	5	9156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DOCK4 SYNE1 AKAP12 ADAMTS12 AKAP9	8.83e-05	200	100	5	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SYNE1 DNAH7 NBPF19 NBPF10 EFR3B	8.83e-05	200	100	5	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SYNE1 DNAH7 NBPF19 NBPF10 EFR3B	8.83e-05	200	100	5	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 SYNE1 TEX15 AKAP12 ADAMTS12	8.83e-05	200	100	5	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	TSNAXIP1 IFT172 SYNE1 DNAH7 CFAP69	8.83e-05	200	100	5	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PARVB CADPS ATP2A3 ALOX5 VAV1	8.83e-05	200	100	5	566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SYNE1 DNAH7 NBPF19 NBPF10 EFR3B	8.83e-05	200	100	5	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SYNE1 DNAH7 NBPF19 NBPF10 EFR3B	8.83e-05	200	100	5	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 SYNE1 TEX15 AKAP12 ADAMTS12	8.83e-05	200	100	5	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SYNE1 DNAH7 NBPF19 NBPF10 EFR3B	8.83e-05	200	100	5	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 SYNE1 TEX15 AKAP12 ADAMTS12	8.83e-05	200	100	5	bd8cf33502adea320e91ca2af14e1911d88ad374
Drug	trimethylsilanol	SYNE1 DMPK ALOX5	1.58e-06	6	99	3	CID000066110
Drug	lanthanum	CDH23 ITPR3 GUCY2C GSTCD ATP2A1 ATP2A2 ATP2A3	2.19e-06	136	99	7	CID000023926
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	RAD51B TSNAXIP1 CNNM2 TSC22D3 ADAMTS12 PAPOLA DMPK CFAP69	2.29e-06	196	99	8	3724_DN
Drug	AC1L1G0K	TRPV3 ATP2A1 ATP2A2 ATP2A3 ALOX5	2.30e-06	49	99	5	CID000003473
Drug	Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A	CNNM2 VEZT TSC22D3 CEP290 DNAJC28 MICAL3 DMPK VAV1	2.47e-06	198	99	8	7013_UP
Drug	Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	CNNM2 VEZT IGFLR1 PAPOLA GSTCD SMARCA2 MAP3K9 CFAP69	2.47e-06	198	99	8	6315_UP
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A	RAD51B TSNAXIP1 CNNM2 ATAD5 CEP290 AKAP9 GSTCD SMARCA2	2.57e-06	199	99	8	1705_UP
Drug	CC270	TRIM21 DMPK ATP2A1 ATP2A2 ATP2A3	5.83e-06	59	99	5	CID006918852
Drug	tricyclohexyltin chloride	GSTCD ATP2A1 ATP2A3	9.36e-06	10	99	3	CID000076539
Drug	ATP-EDC	ATP2A1 ATP2A2 ATP2A3	9.36e-06	10	99	3	CID000195647
Drug	1sqc	ATP2A1 ATP2A2 ATP2A3	9.36e-06	10	99	3	CID000444279
Drug	strontium	CNNM2 ITPR3 ATP2A1 ATP2A2 ATP2A3	1.18e-05	68	99	5	CID000104798
Drug	2,5-dimethylquinone	ATP2A1 ATP2A2 ATP2A3	1.28e-05	11	99	3	CID000008718
Drug	1vyq	ATP2A1 ATP2A2 ATP2A3	1.71e-05	12	99	3	CID004369390
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	RAD51B ATAD5 CEP290 RB1CC1 IGFLR1 AKAP9 TACC1	1.71e-05	186	99	7	1664_UP
Drug	2,6-dichlorobenzaldehyde	GSTCD DMPK	1.87e-05	2	99	2	CID000006737
Drug	mag-fura-2	ITPR3 ATP2A1 ATP2A2 ATP2A3	1.99e-05	37	99	4	CID000123839
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RAD51B ATAD5 AKAP9 PAPOLA TACC1 PLEC DMPK	2.17e-05	193	99	7	4846_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A	CNNM2 BAZ1B UST DNAH7 DNAJC28 PAPOLA GSTCD	2.32e-05	195	99	7	7135_UP
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A	RAD51B CEP290 KIAA0319L BAZ1B PAPOLA SMARCA2 DMPK	2.40e-05	196	99	7	5005_DN
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	CNNM2 ATAD5 BAZ1B IGFLR1 AKAP12 TACC1 PLEC	2.48e-05	197	99	7	7347_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	RAD51B TSNAXIP1 VEZT TSC22D3 TEX15 DNAJC28 DMPK	2.48e-05	197	99	7	3727_DN
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	TSC22D3 ATAD5 BAZ1B DNAH7 PAPOLA GSTCD ALOX5	2.48e-05	197	99	7	4190_DN
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	RAD51B CNNM2 TSC22D3 BAZ1B MLH3 DNAJC28 TACC1	2.56e-05	198	99	7	6489_DN
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	RAD51B PGS1 ATAD5 CEP290 KIAA0319L DNAJC28 ATP2A3	2.56e-05	198	99	7	5019_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; PC3; HT_HG-U133A	TOR1AIP2 CHMP6 BAZ1B IGFLR1 AKAP9 TACC1 PLEC	2.65e-05	199	99	7	1817_DN
Drug	p-hydroxyhippuric acid	ATP2A1 ATP2A2 ATP2A3	2.80e-05	14	99	3	CID000151012
Drug	alpha-naphthylthiourea	IL13 DMPK ATP2A1 ATP2A2 ATP2A3	3.30e-05	84	99	5	CID000736366
Drug	XeC compound	ITPR3 B4GALNT2 ATP2A1 ATP2A2 ATP2A3	3.30e-05	84	99	5	CID000005701
Drug	NSC239129	ATP2A1 ATP2A2 ATP2A3	3.49e-05	15	99	3	CID000084597
Drug	benzoquinone	SYNE1 POLA2 GSTCD ATP2A1 ATP2A2 ATP2A3 ALOX5	3.62e-05	209	99	7	CID000004650
Drug	clotrimazole	GSTCD PLEC ATP2A1 ATP2A2 ATP2A3 ALOX5	3.83e-05	143	99	6	CID000002812
Drug	AC1L88YH	ATP2A1 ATP2A2 ATP2A3	5.19e-05	17	99	3	CID000374551
Drug	4-phenylthiosemicarbazide	SYNE1 DMPK	5.60e-05	3	99	2	CID000730679
Drug	indo-1	TUFM ITPR3 ATP2A1 ATP2A2 ATP2A3	7.27e-05	99	99	5	CID000105060
Drug	AC1L380G	ATP2A1 ATP2A2 ATP2A3	7.35e-05	19	99	3	CID000084698
Drug	methyl phosphate	DMPK ATP2A1 ATP2A3	8.62e-05	20	99	3	CID000013130
Drug	acetazolamide	RB1CC1 DMPK ATP2A1 ATP2A2 ATP2A3	1.05e-04	107	99	5	CID000001986
Drug	Gsch2cl	POLA2 GSTCD	1.12e-04	4	99	2	CID000158382
Drug	Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; HL60; HT_HG-U133A	ACAP1 TSC22D3 BAZ1B PARVB RB1CC1 SMARCA2	1.14e-04	174	99	6	1873_UP
Drug	toxaphene	SCRIB ATP2A1 ATP2A2 ATP2A3	1.19e-04	58	99	4	CID005284469
Drug	AC1L25Y6	ATP2A1 ATP2A2 ATP2A3	1.33e-04	23	99	3	CID000015465
Drug	lanthanum chloride hydrate	ATP2A1 ATP2A2 ATP2A3	1.33e-04	23	99	3	CID000165791
Drug	6-formylindolo(3,2-b)carbazole	SYNE1 ATP2A1 ATP2A2 ATP2A3	1.36e-04	60	99	4	ctd:C111855
Drug	EUK-8	ATP2A1 ATP2A2 ATP2A3	1.71e-04	25	99	3	CID000171249
Drug	cyhexatin	ATP2A1 ATP2A2 ATP2A3	1.71e-04	25	99	3	CID005364545
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	CNNM2 CEP290 ITPR3 PAPOLA TACC1 PLEC	1.74e-04	188	99	6	4845_DN
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	ATAD5 TRIM21 CNNM1 TACC1 PLEC ATP2A3	1.79e-04	189	99	6	6831_DN
Drug	allodeoxycholic acid	B4GALNT2 DMPK ATP2A1 ATP2A2 ATP2A3 SLC23A1	1.84e-04	190	99	6	CID000002987
Drug	4-acetylpyridine	SYNE1 DYNC1H1	1.86e-04	5	99	2	CID000014282
Drug	2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A	TSNAXIP1 CHMP6 ATAD5 CEP290 SMARCA2 CFAP69	1.89e-04	191	99	6	1240_UP
Drug	dodecyl ether	ATP2A1 ATP2A2 ATP2A3	1.93e-04	26	99	3	CID000020667
Drug	fluo-3	ITPR3 B4GALNT2 ATP2A1 ATP2A2 ATP2A3	1.95e-04	122	99	5	CID000104978
Drug	Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RAD51B DOCK4 SYNE1 KIAA0319L TEX15 ATP2A2	2.00e-04	193	99	6	2764_UP
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	ATAD5 SYNE1 BAZ1B SMARCA2 ATP2A2 ATP2A3	2.00e-04	193	99	6	2093_UP
Drug	Clorocruoro Hem	ITPR3 DMPK ATP2A1 ATP2A2 ATP2A3	2.02e-04	123	99	5	CID003518809
Drug	Les T	IGFLR1 DMPK ATP2A1 ATP2A2 ATP2A3	2.02e-04	123	99	5	CID000003189
Drug	Iopanoic acid [96-83-3]; Up 200; 7uM; HL60; HT_HG-U133A	REC8 TSNAXIP1 ACAP1 TSC22D3 PLEC ATP2A3	2.06e-04	194	99	6	2965_UP
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	RAD51B BAZ1B AKAP9 PAPOLA SMARCA2 MICAL3	2.06e-04	194	99	6	3274_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A	TSNAXIP1 VEZT ATAD5 CEP290 MLH3 AKAP9	2.12e-04	195	99	6	7254_UP
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	RAD51B TSC22D3 PAPOLA MICAL3 PLEC ATP2A3	2.17e-04	196	99	6	3329_DN
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	VEZT BAZ1B ADAMTS12 TACC1 DMPK ATP2A1	2.17e-04	196	99	6	2217_UP
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A	ACAP1 TSC22D3 SYNE1 CEP290 KIAA0319L BAZ1B	2.17e-04	196	99	6	3069_DN
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	RAD51B ACAP1 CNNM1 EFR3B DMPK ATP2A3	2.17e-04	196	99	6	1642_UP
Drug	radicicol; Up 200; 0.1uM; SKMEL5; HG-U133A	ZKSCAN8 POLA2 ITPR3 GLMN GSTCD MICAL3	2.17e-04	196	99	6	493_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A	ATAD5 SYNE1 BAZ1B IGFLR1 PAPOLA MAP3K9	2.17e-04	196	99	6	7155_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A	RAD51B VEZT ATAD5 BAZ1B PARVB VAV1	2.17e-04	196	99	6	6469_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; HL60; HT_HG-U133A	SYNE1 CEP290 KIAA0319L DNAH7 LLGL1 ATP2A3	2.23e-04	197	99	6	2351_UP
Drug	Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; MCF7; HT_HG-U133A	CNNM2 ATAD5 BAZ1B CNNM1 MLH3 GSTCD	2.23e-04	197	99	6	1486_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; HL60; HG-U133A	ACAP1 CNNM2 IGFLR1 EFR3A ADAMTS12 LLGL1	2.23e-04	197	99	6	1388_UP
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	CNNM2 VEZT ZKSCAN8 LLGL1 TRIM17 DMPK	2.23e-04	197	99	6	4679_UP
Drug	DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A	CHMP6 UST MLH3 TACC1 PLEC KLHL18	2.23e-04	197	99	6	7462_DN
Drug	Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A	RAD51B TSC22D3 ATAD5 CNNM1 SMARCA2 TACC1	2.23e-04	197	99	6	3171_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	ATAD5 RB1CC1 PAPOLA TACC1 SCRIB ATP2A3	2.23e-04	197	99	6	5564_DN
Drug	Sulmazole [73384-60-8]; Down 200; 14uM; PC3; HT_HG-U133A	RAD51B SYNE1 TRIM21 DNAH7 CNNM1 ATP2A2	2.23e-04	197	99	6	4009_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	DOCK4 CNNM2 CEP290 TRIM21 CNNM1 MLH3	2.23e-04	197	99	6	2324_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	ATAD5 CEP290 BAZ1B CNNM1 GSTCD SMARCA2	2.23e-04	197	99	6	5361_DN
Drug	5'-pCAA-3'	ITPR3 DMPK ATP2A1 ATP2A2 ATP2A3	2.26e-04	126	99	5	CID000482140
Drug	nitrendipine; Down 200; 10uM; MCF7; HG-U133A	PGS1 CEP290 AKAP12 LLGL1 SMARCA2 EFR3B	2.30e-04	198	99	6	336_DN
Drug	Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	BAZ1B UST AKAP9 GSTCD SMARCA2 DMPK	2.30e-04	198	99	6	3554_DN
Drug	Biotin [58-85-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A	TSC22D3 BAZ1B CNNM1 GSTCD TACC1 ATP2A3	2.30e-04	198	99	6	3289_DN
Drug	tBuBHQ	B4GALNT2 ATP2A1 ATP2A2 ATP2A3	2.34e-04	69	99	4	CID000002374
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; PC3; HT_HG-U133A	CNNM2 VEZT ATAD5 TRIM21 MLH3 ATP2A2	2.36e-04	199	99	6	7134_UP
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; HL60; HT_HG-U133A	REC8 CNNM2 TSC22D3 BAZ1B AKAP9 GSTCD	2.36e-04	199	99	6	1863_UP
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; PC3; HT_HG-U133A	RAD51B VEZT TEX15 CNNM1 PAPOLA GSTCD	2.36e-04	199	99	6	4484_DN
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; PC3; HT_HG-U133A	CNNM2 TSC22D3 CNNM1 PAPOLA GSTCD CFAP69	2.36e-04	199	99	6	4209_DN
Drug	Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RAD51B ATAD5 BAZ1B CNNM1 PAPOLA INTS9	2.36e-04	199	99	6	6475_DN
Drug	Bretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	CNNM2 ATAD5 BAZ1B TRIM21 PAPOLA GSTCD	2.36e-04	199	99	6	6674_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; PC3; HT_HG-U133A	VEZT CEP290 TRIM21 PARVB SMARCA2 MAP3K9	2.42e-04	200	99	6	6321_UP
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A	RAD51B SYNE1 BAZ1B DNAJC28 CFAP69 ATP2A3	2.42e-04	200	99	6	2116_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	RAD51B TSC22D3 CEP290 PAPOLA TACC1 ATP2A2	2.42e-04	200	99	6	6503_DN
Drug	daunorubicin semiquinone	SYNE1 POLA2 GSTCD DMPK ATP2A1 ATP2A2 ATP2A3	2.50e-04	285	99	7	CID000002958
Drug	Pyrethroids	DMPK ATP2A1 ATP2A2 ATP2A3	2.61e-04	71	99	4	CID000005053
Drug	octaethylene glycol	ATP2A1 ATP2A2 ATP2A3	2.68e-04	29	99	3	CID000078798
Drug	monobromobimane	GSTCD ATP2A1 ATP2A2 ATP2A3	2.76e-04	72	99	4	CID000114810
Drug	L-699,333	GSTCD ALOX5	2.78e-04	6	99	2	CID000127911
Drug	AC1L9QEM	SYNE1 ALOX5	2.78e-04	6	99	2	CID000452587
Drug	AC1Q7BER	ITPR3 ATP2A1	2.78e-04	6	99	2	CID000005702
Drug	C13932	ITPR3 B4GALNT2 TRPV3 ATP2A1 ATP2A2 ATP2A3	2.84e-04	206	99	6	CID000168297
Drug	leukotriene-C4	IL13 GSTCD ALOX5	3.28e-04	31	99	3	CID000000859
Disease	Brody myopathy (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	3.13e-08	3	94	3	DOID:0050692 (implicated_via_orthology)
Disease	level of UL16-binding protein 6 in blood serum	ULBP2 RAET1L	1.00e-05	2	94	2	OBA_2043185
Disease	VACTERL association (implicated_via_orthology)	IFT172 TBC1D32	1.49e-04	6	94	2	DOID:14679 (implicated_via_orthology)
Disease	cancer (implicated_via_orthology)	ACAP1 PARVB LLGL1 SMARCA2 KANK4 SCRIB	2.22e-04	268	94	6	DOID:162 (implicated_via_orthology)
Disease	visceral heterotaxy (implicated_via_orthology)	CEP290 CCDC39 TBC1D32	2.25e-04	37	94	3	DOID:0050545 (implicated_via_orthology)
Disease	heart disease (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	2.44e-04	38	94	3	DOID:114 (implicated_via_orthology)
Disease	Inherited susceptibility to asthma	IL13 ALOX5	2.78e-04	8	94	2	cv:C1869116
Disease	ASTHMA, SUSCEPTIBILITY TO	IL13 ALOX5	2.78e-04	8	94	2	600807
Disease	cystic kidney disease (implicated_via_orthology)	IFT172 CEP290	4.44e-04	10	94	2	DOID:2975 (implicated_via_orthology)
Disease	kidney cancer (implicated_via_orthology)	LLGL1 SCRIB	5.42e-04	11	94	2	DOID:263 (implicated_via_orthology)
Disease	Bardet-Biedl Syndrome	IFT172 CEP290	7.65e-04	13	94	2	C0752166
Disease	bipolar I disorder	SYNE1 CNNM3 PLEC ATP2A2	1.09e-03	141	94	4	EFO_0009963
Disease	glucose homeostasis measurement, acute insulin response measurement	ATP2A2 ATP2A3	1.49e-03	18	94	2	EFO_0006831, EFO_0006896
Disease	hydrocephalus (implicated_via_orthology)	CCDC39 ULK4	1.66e-03	19	94	2	DOID:10908 (implicated_via_orthology)
Disease	mental development measurement	PCDHGA4 EFR3A	2.87e-03	25	94	2	EFO_0008230
Disease	cortical thickness	RAD51B CNNM2 CADPS MICAL3 MAEL TACC1 PLEC ZSWIM4 KLHL18 MIEF2	2.88e-03	1113	94	10	EFO_0004840
Disease	severe acute respiratory syndrome, COVID-19	PGS1 ADAMTS12 CADPS ULBP2 RAET1L SLC23A1	3.10e-03	447	94	6	EFO_0000694, MONDO_0100096
Disease	HMG CoA reductase inhibitor use measurement	ITPR3 SPC24 B4GALNT2 PLEC	3.17e-03	189	94	4	EFO_0009932

Protein segments in the cluster

Peptide	Gene	Start	Entry
VLTLIREEIITKEIE	TACC1	606	O75410
VVIQEEELELAVLEA	ATAD5	371	Q96QE3
LEIDVEEQVSRFIEL	AKAP9	2026	Q99996
VIDIIDRLIILNSEA	TBC1D32	826	Q96NH3
IEVLVDVLEKTELDV	B4GALNT2	411	Q8NHY0
LLTEEVLEREVIAEE	AKAP12	931	Q02952
ELIRSLTELQELEAV	COG4	31	Q9H9E3
VILLQTLLQDEIAED	BAZ1B	656	Q9UIG0
IELVEAEVSELETRL	ACAP1	21	Q15027
TVDLELELQIELLRE	ARFIP2	121	P53365
VLFLETLVELEVLQD	CCR4	261	P51679
ILEELSAITQEQIEL	CHMP6	156	Q96FZ7
RITVILEDIDECQEL	FBN3	1556	Q75N90
LDLVADLTLQEVRVV	CDH23	2821	Q9H251
DLTLQEVRVVLEDIN	CDH23	2826	Q9H251
ELANEEVVIDLIRLA	EFR3A	561	Q14156
EVVIDLIRLAIALQD	EFR3A	566	Q14156
ELVIEQFEDLLVRIL	ATP2A1	51	O14983
ELVLEQFEDLLVRIL	ATP2A3	51	Q93084
IHIVVVRLILLEEEE	ADAMTS12	291	P58397
MLVDIIEENTEIRII	CCDC39	841	Q9UFE4
DEVLQRIESLEEEII	RAD51B	186	O15315
LDLLIAEEEEAILLE	REC8	221	O95072
DRAVAEDIVIILVDL	GUCY2C	261	P25092
IVLLQEAETLIQIEE	INTS9	616	Q9NV88
IIEKLQDIITALEER	ITPR3	1591	Q14573
LAVLLEEELVVLDLQ	LLGL1	361	Q15334
LEDTVKILRVEVEII	PCDHGA4	141	Q9Y5G9
VIELLERVKIVEALS	RB1CC1	476	Q8TDY2
DTIRLAELVIEVLQQ	CADPS	881	Q9ULU8
LEVVEQRDSLVALLE	MICAL3	1961	Q7RTP6
IRQDLQLLTVEDLVV	MAEL	236	Q96JY0
LVEIILDINVSQLTE	KIAA0319L	791	Q8IZA0
SLQLIVIQEEVVEID	GINM1	126	Q9NU53
SIVEEFIREQLELLQ	MLH3	1326	Q9UHC1
EIQIDEIVTETLLTE	PGS1	361	Q32NB8
ELANEEVVVDLIRLV	EFR3B	556	Q9Y2G0
EVVVDLIRLVLAVQD	EFR3B	561	Q9Y2G0
DERLVTLLQEVDTIE	CRLF3	71	Q8IUI8
EDITQEERVLLLQFV	HACE1	821	Q8IYU2
ITQAIERLVEDLIQE	DNAJC28	196	Q9NX36
TALRELIEELVNITQ	IL13	41	P35225
MVELVELEIRELLTE	TUFM	191	P49411
VTLRELQEALEEEVL	DMPK	466	Q09013
VLTREELLANTELVE	IFT172	786	Q9UG01
LVEERIIVKQLEEDL	PARVB	101	Q9HBI1
VFEEEEELQRRILIL	PAPOLA	51	P51003
ELVIEQFEDLLVRIL	ATP2A2	51	P16615
LEDVLELVSRDELNV	KLHL18	181	O94889
VLEEIDVIVASLLDI	DOCK4	871	Q8N1I0
QILLKEIESLEEERL	CEP290	536	O15078
ELEVQEDLLTIINLT	EPM2AIP1	201	Q7L775
NENEEILLLRSIIDV	DNAH7	1521	Q8WXX0
SRLLDELEVLEELIV	IGFLR1	251	Q9H665
LEELQEVVLAADLLE	EFCAB13	671	Q8IY85
LIIEEKIDLEVRSLE	DYNC1H1	851	Q14204
NELLLEEIELNISEI	KANK4	296	Q5T7N3
EEAIVLEIQSDILLI	CFAP69	526	A5D8W1
SLLRDDLIQDVEIQI	GSTCD	61	Q8NEC7
LLEIDFAELTLEEII	MAP3K9	136	P80192
EIDILERELNIIIHQ	MAP3K9	476	P80192
EELLLEVQHERLELT	MIEF2	286	Q96C03
DLIESVLARVEELIE	GLMN	566	Q92990
DVALVLTVLLEEETL	TOR1AIP2	391	Q8NFQ8
LLVVVENEDVTVELI	TOM1L1	256	O75674
VLEERISLEVQLEQL	REPS1	776	Q96D71
EIITEDVLEITILEI	TDRD6	1656	O60522
LALLEQELIERFDVE	PPP4R1	156	Q8TF05
GERVDLNEEETILII	SMARCA2	921	P51531
IEIDAQLEELQILLT	SYNE1	5351	Q8NF91
EELEQLQRLELSTDI	SYNE1	8461	Q8NF91
EEVEILKEQIRELVE	TSC22D3	71	Q99576
VTVDEELGEIQLVRI	ALOX5	56	P09917
EIDVLERELNILIFQ	MAP3K21	471	Q5TCX8
LSRELLEVVEPEVLQ	NBPF10	1501	Q6P3W6
LSRELLEVVEPEVLQ	NBPF10	2721	Q6P3W6
LSRELLEVVEPEVLQ	NBPF19	2206	A0A087WUL8
LSRELLEVVEPEVLQ	NBPF19	3426	A0A087WUL8
LSRELLEVVEPEVLQ	NBPF20	886	P0DPF2
LSRELLEVVEPEVLQ	NBPF20	2106	P0DPF2
LSRELLEVVEPEVLQ	NBPF20	3326	P0DPF2
LSRELLEVVEPEVLQ	NBPF20	4471	P0DPF2
DEIILIEKERTDLQL	SNX25	481	Q9H3E2
RIEEEELTLTILRQT	SCRIB	721	Q14160
RDIVSIQELIEVEEE	POLA2	91	Q14181
IQELIEVEEEEEILL	POLA2	96	Q14181
VILLLDSDEELELEQ	SLX4	1151	Q8IY92
ERLLQIISELEEEIQ	C10orf67	261	Q8IYJ2
VTLEDIIEEIIKSEI	CNNM1	551	Q9NRU3
IVTLEDVIEEIIKSE	CNNM2	566	Q9H8M5
VLGLVTLEDVIEEII	CNNM3	431	Q8NE01
TLEDVIEEIIRSEIL	CNNM3	436	Q8NE01
VGILEELEDVLLLLE	UST	281	Q9Y2C2
LYEQVVLELIELREL	SMU1	76	Q2TAY7
ILEVDQILIVLLTTE	SLC23A1	486	Q9UHI7
LLQLTRELEELKEIE	SPC24	101	Q8NBT2
QDIEIIFINIEDLLR	VAV1	231	P15498
EVVDILTEQLLDIQL	RAET1G	96	Q6H3X3
EVVDILTEQLLDIQL	RAET1L	96	Q5VY80
VEQELTTLRLQLEET	PLEC	2321	Q15149
ITIVEEVETLRQERL	PLEC	3426	Q15149
LELLQEVIIVLERSE	TRIM21	241	P19474
LVEEEQRLLQALETE	TRIM17	196	Q9Y577
CVEELVELLVELQEL	TRPV3	131	Q8NET8
EVIEALILDEEVRTF	UBE4A	251	Q14139
NLVLQSIELESEIEI	TEX15	666	Q9BXT5
QEVLLQEDVELIELL	VEZT	101	Q9HBM0
EVVDILTEQLRDIQL	ULBP2	96	Q9BZM5
VEILQTALERLQVID	TSNAXIP1	631	Q2TAA8
VVSLIEDLQRELEIP	ZNF449	101	Q6P9G9
EVVTLLEDLERQIDI	ZKSCAN8	121	Q15776
VEAIVLLTELIRENF	ULK4	551	Q96C45
VVRNEEQLLALLEEV	ZSWIM4	491	Q9H7M6
EQLLALLEEVELDER	ZSWIM4	496	Q9H7M6
LLEEVELDERLVQVL	ZSWIM4	501	Q9H7M6